You can find here our first bibliographies on the following topics
- ATMPs:
- Biosimilars (updated in June 2024)
- Car-T Cells (November 2024)
- Health technology assessment (April 2024)
- Induced pluripotent stem cells (March 2022)
- Medicines development:
- Accelerated Assessment (August 2022)
- Central Marketing Authorisation (November 2022)
- Clinical trial (December 2025)
- Compassionate use (January 2025)
- Conditional Marketing Authorisation (September 2022)
- Manufacturing authorisation (February 2023)
- Marketing Authorisation Application files (October 2022)
- Marketing Authorisation under Exceptional Circumstances (October 2022)
- Medicines transparency (August 2021)
- Packaging and labelling (August 2021)
- Support for innovative medicines’ development:
- ATMP Certification Procedure (April 2025)
- ATMP Pilot Academia (April 2025)
- Innovation Task Force (March 2025)
- Joint Scientific Consultation (March 2025)
- Parallel Scientific Advice (February 2025)
- PRIME (April 2025)
- Protocol Assistance (March 2025)
- Scientific Advice (April 2025)
- Simultaneous National Scientific Advice (March 2025)
- SME Office / SME Status (March 2025)
- Nanomedicine (September 2021)
- Organoids (March 2022)
- Orphan medicines (July 2021)
- Pharmacovigilance (February 2023)
- Quality of medicines (May 2022)
- Regenerative medicine (September 2021)
Stay tuned for more bibliographies in the future.
